Related Experiment Video
Updated: Jun 26, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Update on worldwide efforts to prevent type 1 diabetes
1Diabetes Research Institute, Miami, Florida 33101-6960, USA. jskyler@miami.edu
Annals of the New York Academy of Sciences
|January 6, 2009
Summary
Researchers reviewed global strategies to prevent type 1 diabetes (T1D) before clinical symptoms appear. The aim is to halt autoimmune destruction and delay or stop disease onset through various interventions.
Area of Science:
- Immunology
- Endocrinology
- Preventive Medicine
Background:
- Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction of insulin-producing beta cells.
- Early intervention before clinical onset is crucial for preventing or delaying T1D.
- Understanding the preclinical stages of T1D is key to developing effective prevention strategies.
Purpose of the Study:
- To review global efforts aimed at preventing type 1 diabetes before disease onset.
- To assess interventions targeting the autoimmune process during the preclinical phase of T1D.
- To consolidate findings from randomized controlled trials on T1D prevention.
Main Methods:
- Systematic review of worldwide interventional studies for T1D prevention.
- Analysis of randomized controlled trials (RCTs) conducted prior to clinical T1D diagnosis.
- Evaluation of interventions including nicotinamide, insulin (parenteral, oral, nasal), and dietary modifications.
Main Results:
- Multiple large-scale, multicenter RCTs have investigated various strategies to prevent T1D.
- Interventions tested include pharmacological agents like nicotinamide and insulin, as well as dietary changes.
- The effectiveness of these interventions in arresting immune destruction and preventing T1D requires further analysis.
Conclusions:
- Worldwide efforts focus on preventing type 1 diabetes by intervening before clinical symptoms.
- Preclinical interventions aim to halt the autoimmune destruction of beta cells.
- Diverse strategies, including immunomodulation and dietary approaches, are under investigation for T1D prevention.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...